Login to Your Account



Pharma: Other News To Note


Tuesday, July 2, 2013
• Noven Pharmaceuticals Inc., of Miami, said the FDA approved Brisdelle low-dose paroxetine capsules, 7.5 mg/day, for the treatment of moderate to severe vasomotor symptoms associated with menopause, the first nonhormonal treatment for hot flashes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription